Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Jiaying Pharma to IPO in Shenzhen

publication date: Nov 28, 2007
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Guangdong Jiaying Pharmaceutical has been approved to make its IPO on the Shenzhen stock exchange. The company will issue 20.5 million shares, which will represent 25% of the outstanding shares after the IPO. The five owners of Jiaying have agreed to a 36-month lockup of their personal holdings in the company. Jiaying plans to raise a total of 175 million RMB ($23.6 million) in the offering, implying a price of 8.5 RMB per share. Jiaying will use the money to expand its production facility and build a distribution center. More details...




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners